Thursday, 7 August 2014

4 China medical news links for Thursday ...

China will become one of the largest global markets for prescription drugs, growing to $260 billion in 2020, a University of Kansas study finds. Generic drugs will account for more prescriptions, but there will still be major problems for health providers to meet consumer demand for brand name innovative drugs and also to provide universal access to affordable medicines, the researchers say.

Beijing's air quality has not improved over the last nine years, with air pollution exceeding Grade II of NAAQS levels for Pm2.5  and PM10 on more than 30 % of day, a study has found. The worst levels occurred at dawn and dusk, whereas midday had lower levels of air pollution. The source of air pollution was road vehicles and heavy industry especially to the south of the city, according to Dr Liu Zirui and co-researchers from the State Key Laboratory of Atmospheric Boundary Layer Physics and Atmospheric Chemistry (LAPC), Chinese Academy of Sciences, Beijing.

Treatment of breast cancer in China has improved in the last decade, but many women still miss out on radiotherapy and endocrine therapy, say oncologists at the West China Hospital, Chengdu. IN a review, they found that chemotherapy was the most popular therapy, but the proportion of women receiving radiation therapy increased from 37% in 2001 to 67% in 2011 . At the same time, use of endocrine therapy from 54% to 86%, they found.

Hand foot and mouth disease is a serious and common illness in China, with more than  five million cases reported over a five year period from 2008 to 2012. The disease caused more than 1200 major outbreaks, caused predominantly by enterovirus 71 and cocksackie virus, with most occurring in April–June and a smaller  peak in September–November. The survey was done by researchers at the Key Laboratory of Surveillance and Early-warning on Infectious Disease, Chinese Centre for Disease Control and Prevention, Beijing.

No comments:

Post a comment

Add a comment